CHEC
NASDAQ · N/A
Chenghe Acquisition Ii-Cl A
$10.23
+0.00 (+0.00%)
Open$10.23
Previous Close$10.23
Day High$10.23
Day Low$10.23
52W High$10.56
52W Low$9.91
Volume—
Avg Volume22.9K
Market Cap176.72M
P/E Ratio88.68
EPS$0.12
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 47.33M | 48.76M | 38.65M |
| Net Income | 6.62M | 6.62M | 5.16M |
| Profit Margin | 14.0% | 13.6% | 13.4% |
| EBITDA | 11.01M | 10.93M | 9.56M |
| Free Cash Flow | 2.96M | 3.79M | 2.92M |
| Rev Growth | -1.7% | -6.8% | +21.0% |
| Debt/Equity | 0.74 | 0.79 | 0.68 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.41B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.9 | 595.50M |